bluebird bio
BLUE
$0.89
Share price
-3.30%
Change (1 day)
-74.06%
Change (1 year)
Market capitalization of bluebird bio (BLUE)
Market cap: $0.17 Billion
As of April 2024 bluebird bio has a market cap of $0.17 Billion. This makes bluebird bio the world's 7044th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of bluebird bio from 2013 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.17 B | -35.33% |
| 2023 | $0.26 B | -53.64% |
| 2022 | $0.57 B | -18.08% |
| 2021 | $0.70 B | -75.61% |
| 2020 | $2.87 B | -40.89% |
| 2019 | $4.85 B | -10.52% |
| 2018 | $5.43 B | -37.87% |
| 2017 | $8.74 B | 279.73% |
| 2016 | $2.30 B | -2.86% |
| 2015 | $2.36 B | -20.12% |
| 2014 | $2.96 B | 490.57% |
| 2013 | $0.50 B |
End of Day market cap according to different sources
On Apr 24th, 2024 the market cap of bluebird bio was reported to be:
$0.17 Billion
$0.17 Billion
$0.10 Billion
$0.10 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $124.54 B | 72,306.66% | 🇫🇷 France |
 Merck MRK | $331.21 B | 192,465.86% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | $99.53 M | -42.13% | 🇺🇸 USA |
 Acceleron Pharma XLRN | $10.93 B | 6,255.47% | 🇺🇸 USA |
 GlycoMimetics
GLYC | $0.11 B | -34.05% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $15.72 B | 9,042.14% | 🇺🇸 USA |